GlassScriptPhysician profile
Ammar Habib
NPI 1558526285
$11,249.84
in general payments reported to CMS, 2019-2025
43 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,488 · 2020: $873 · 2021: $1,432 · 2022: $1,724 · 2023: $2,079 · 2024: $1,168 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,356 · Travel and Lodging: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,356.36 |
| Travel and Lodging | $1,375.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,275.10 | 2019-2025 | Mitraclip, Cardiomems, Ultreon |
| Boston Scientific Corporation | $1,784.21 | 2019-2025 | Farapulse, Watchman Access System, Versacross Steerable Access Solution |
| Medtronic, INC. | $1,343.06 | 2021-2025 | Corevalve Evolut R, Resolute Onyx |
| Amgen INC. | $767.01 | 2019-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $720.21 | 2019-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $439.56 | 2019-2025 | Farxiga, Andexxa |
| Janssen Pharmaceuticals, INC | $386.19 | 2019-2023 | Xarelto |
| Pfizer INC. | $273.65 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $264.56 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $250.23 | 2019-2024 | |
| Novo Nordisk INC | $240.56 | 2022-2024 | Ozempic, Wegovy, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $234.73 | 2019-2025 | Eliquis |
| Medtronic Vascular, INC. | $216.51 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $182.76 | 2019-2025 | |
| Lantheus Medical Imaging, INC. | $164.46 | 2019-2025 | Definity |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $161.56 | 2021-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.73 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $144.69 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.16 | 2019-2023 | Jardiance |
| Amarin Pharma, INC. | $124.94 | 2019-2021 | |
| Acist Medical Systems, INC. | $106.19 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $86.17 | 2022-2025 | Opsumit, Uptravi |
| Philips North America LLC | $77.54 | 2022-2025 | Coronary Other |
| Cardiva Medical, INC. | $72.13 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Chiesi USA, INC. | $62.98 | 2021-2025 | Kengreal |
| Alnylam Pharmaceuticals INC. | $56.17 | 2022-2025 | Onpattro |
| Impulse Dynamics (USA) INC. | $49.55 | 2021-2022 | |
| Inari Medical, INC. | $45.22 | 2022 | |
| Terumo Medical Corporation | $41.81 | 2021-2024 | Azur Cx Detachable, Angio-Seal |
| Regeneron Healthcare Solutions, INC. | $40.78 | 2019-2023 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $40.61 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $39.04 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Baxter Healthcare | $37.89 | 2024 | Perclot |
| Lexicon Pharmaceuticals, INC. | $33.33 | 2023 | Inpefa |
| Angiodynamics, INC. | $29.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.80 | 2022 | |
| Daiichi Sankyo INC. | $25.43 | 2022 | |
| Penumbra, INC. | $23.67 | 2019-2021 | |
| Atricure, INC. | $21.37 | 2022 | |
| Esperion Therapeutics, INC. | $18.93 | 2021 | |
| Ge Healthcare | $17.81 | 2022 | |
| Scpharmaceuticals INC. | $15.91 | 2025 | |
| Gilead Sciences, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Habib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.